These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38672082)

  • 21. A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.
    Li J; Lin J; Ji Y; Wang X; Fu D; Wang W; Shen B
    Cell Oncol (Dordr); 2023 Oct; 46(5):1381-1398. PubMed ID: 37138146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissection of tumor antigens and immune landscape in clear cell renal cell carcinoma: Preconditions for development and precision medicine of mRNA vaccine.
    Hu J; Mo Z
    Math Biosci Eng; 2023 Jan; 20(2):2157-2182. PubMed ID: 36899527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development.
    Lu T; Xu R; Wang CH; Zhao JY; Peng B; Wang J; Zhang LY
    Front Genet; 2022; 13():853113. PubMed ID: 35734437
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development.
    Wang G; Gao Y; Chen Y; Wang K; Zhang S; Li G
    Front Oncol; 2022; 12():921711. PubMed ID: 35814377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of tumor antigens and immunogenic cell death landscapes of prostate adenocarcinoma for exploration of mRNA vaccine.
    Yu G; Lin Y; Wang J; Zhou L; Lu Y; Fei X; Gu X; Song S; Wang J; Liu Y; Yang Q; Zhan M; Seo SY; Xu B
    Expert Rev Vaccines; 2024; 23(1):830-844. PubMed ID: 39193620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinoma.
    Chen H; Zhang J; Sun X; Wang Y; Qian Y
    Front Cell Dev Biol; 2022; 10():901207. PubMed ID: 35938160
    [No Abstract]   [Full Text] [Related]  

  • 27. Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development.
    Wu C; Qin C; Long W; Wang X; Xiao K; Liu Q
    J Big Data; 2022; 9(1):92. PubMed ID: 35855914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
    Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D
    Front Genet; 2021; 12():692953. PubMed ID: 34490033
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of colon adenocarcinoma necroptosis subtypes and tumor antigens for the development of mRNA vaccines.
    Luo Y; Lu C; Huang Y; Liao W; Huang Y
    Heliyon; 2024 Jun; 10(12):e32531. PubMed ID: 38952359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development.
    Ye L; Wang L; Yang J; Hu P; Zhang C; Tong S; Liu Z; Tian D
    Front Genet; 2021; 12():701065. PubMed ID: 34527020
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning.
    Liu LP; Lu L; Zhao QQ; Kou QJ; Jiang ZZ; Gui R; Luo YW; Zhao QY
    Front Cell Dev Biol; 2021; 9():756340. PubMed ID: 34805165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of Tumor Antigens and Construction of Immune Subtypes for mRNA Vaccine Development in Head and Neck Squamous Cell Carcinoma.
    Li HX; Liu TR; Tu ZX; Xie CB; Wen WP; Sun W
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of lung adenocarcinoma tumor antigens and ferroptosis subtypes for developing mRNA vaccines.
    Chen Y; Zhang C; Li Y; Tan X; Li W; Tan S; Liu G
    Sci Rep; 2024 Feb; 14(1):3219. PubMed ID: 38331967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyroptosis-related gene signature: A predictor for overall survival, immunotherapy response, and chemosensitivity in patients with pancreatic adenocarcinoma.
    Zhou J; Fan J; Li B; Sun J; Wang J
    Heliyon; 2023 Dec; 9(12):e23004. PubMed ID: 38125471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma.
    Xu H; Zheng X; Zhang S; Yi X; Zhang T; Wei Q; Li H; Ai J
    Mol Cancer; 2021 Dec; 20(1):159. PubMed ID: 34872567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma.
    Gao Y; Wang G; Chen Y; Zhang M; Gao W; Shang Z; Niu Y
    Front Genet; 2022; 13():886983. PubMed ID: 35547260
    [No Abstract]   [Full Text] [Related]  

  • 37. Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making.
    Zhu J; Shi Y; Lan S; Wang J; Jiang F; Tang C; Cai Y; Pan Z; Jian H; Fang H; Zhang Y; Zhong F
    Apoptosis; 2023 Jun; 28(5-6):769-782. PubMed ID: 36882663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development.
    Lu TL; Li CL; Gong YQ; Hou FT; Chen CW
    World J Gastrointest Oncol; 2023 Oct; 15(10):1717-1738. PubMed ID: 37969406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD.
    Dong P; Du X; Yang T; Li D; Du Y; Wei Y; Sun J
    Oncol Lett; 2023 Dec; 26(6):512. PubMed ID: 37920431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a Pyroptosis-Related Gene Signature and Effect of Silencing the
    Chen Y; Liu Y; Wang M
    Int J Gen Med; 2022; 15():3199-3213. PubMed ID: 35342302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.